气球子对血液静止的形态效应:对血液静止问题的有希望的解决方案
Xuechang Pei1, Yue Feng2, Yanru Wu1
1Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, Guangdong, 510632, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 28, 2025
概括
球子提供了一种新的静血材料,通过独特的水分去除和表面特性有效地促进血液凝结. 这种传统的药物显示出与商业药物相比的疗效,并提高了伤口愈合的安全性.
科学领域:
- 生物材料科学 生物材料科学
- 伤口治愈研究研究 伤口治愈研究
- 传统医学的传统医学.
背景情况:
- 静血材料对于伤口愈合至关重要,但当前的水友和疏水性选择有局限性.
- 水友性材料可能会导致过度出血和去除困难,而疏水性材料可能会阻碍凝血.
- 波夫球 (Bovistella sp.) 是一种球. 子代表着一种传统的静血剂,有可能克服这些挑战.
研究的目的:
- 为了研究吸血球子的静血性质和作用机制.
- 为了比较球子的疗效和安全性与商业化血静剂.
- 探索球子的潜力,作为开发先进的静血材料的模型.
主要方法:
- 球子形态和表面特性的表征.
- 血液静止功效的体外评估,包括血液凝结和水分去除.
- 与商业化血静剂 (QuikClot) 相比的比较分析.
主要成果:
- 球子具有独特的空洞球杆形态和纳米突出,创造了一个有纹理的疏水表面.
- 通过子有效地去除水分,可以促进血液凝结,而不会过度粘附,与典型的亲水性材料不同.
- 静血疗效与QuikClot可比,观察到安全性提高和副作用减少.
结论:
- 球子表现出显著的静血潜力,为现有材料提供了有效和安全的替代品.
- 球子独特的物理化学特性为设计下一代静血剂提供了蓝图.
- 这项研究强调了基于材料的方法来理解传统医学,超越了成分分析.
相关概念视频
01:05Introduction to Hemostasis
4.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.7K
01:24Disorders of Hemostasis
676
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
676
01:16Clot Retraction and Fibrinolysis
3.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.3K
01:22Formation of the Platelet Plug
3.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.7K